News

The Strategy trailed its core benchmark but bested its growth index, supported by strength among communication services and ...
Haleon has gained full control of its Chinese joint venture after acquiring Tianjin Pharmaceutical Da Ren Tang's 12% stake.
Kepler Capital analyst Karel Zoete maintained a Buy rating on Haleon PLC (HLN – Research Report) on April 8 and set a price target of p440.00.
Investing.com -- Moody's Ratings has upgraded the long-term issuer rating of Haleon plc and its guaranteed subsidiaries to A3 from Baa1. The rating agency also upgraded the rating on Haleon's ...
Italy's Lavazza has unveiled Tablì, an innovative single-serve coffee system featuring 100% 'coffee tabs' and a specially ...
GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Shares in GSK lost 8% of their value today in the wake of the analyst comments, while Sanofi fell 3% and Haleon was down 6%, collectively wiping tens of billions of dollars off their valuations.
Haleon plc (LSE/NYSE:HLN), a global leader in consumer health with a market capitalization of $43 billion, reported on Monday that two of its top executives have participated in the company’s Share ...